Cintas (CTAS) Equity Income (2016 - 2017)
Quarterly results put Equity Income at $100.3 million for Q3 2017, changed N/A from a year ago — trailing twelve months through Aug 2017 was $100.3 million (up 590.75% YoY), and the annual figure for FY2015 was $21.7 million, changed.
Cintas has reported Equity Income over the past 5 years, most recently at $100.3 million for Q3 2017.
- Equity Income reached $100.3 million in Q3 2017 per CTAS's latest filing, up from -$25.9 million in the prior quarter.
- Across five years, Equity Income topped out at $364.3 million in Q4 2015 and bottomed at -$349.7 million in Q2 2016.
- Median Equity Income over the past 3 years was $25.9 million (2016), compared with a mean of $18.1 million.
- The largest annual shift saw Equity Income tumbled 1429.35% in 2016 before it skyrocketed 92.6% in 2017.
- Over 3 years, Equity Income stood at $364.3 million in 2015, then plummeted by 92.9% to $25.9 million in 2016, then skyrocketed by 287.5% to $100.3 million in 2017.
- Business Quant data shows Equity Income for CTAS at $100.3 million in Q3 2017, -$25.9 million in Q2 2017, and $25.9 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | - |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | - |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | - |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | - |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | - |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | - |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 24.00 Mn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2017 | 100.27 Mn |
| May 31, 2017 | -25.88 Mn |
| Nov 30, 2016 | 25.88 Mn |
| May 31, 2016 | -349.74 Mn |